Global / Innovative Pharma Doubles Down on IP with New Pact
On World Intellectual Property (IP) Day 2021, the innovative biopharmaceutical industry came together to launch a…
Top Stories
USA / U-Turn as Biden Pledges Support for Waiver on COVID-19 Vaccine IP
In a shock move, Joe Biden’s administration looks set to support a waiver on intellectual property (IP) protections for COVID-19 vaccines. The decision – which comes amid worrying situations…
Spain / Market Growth; Esteve’s US Expansion; PTS Acquisition
The latest from Spanish pharma, including the acquisition of PTS by a private equity group for its nanoparticle…
China / EpimAb Looks to 2022 IPO & Global Leadership in Bispecific Antibodies
Hot on the heels of a USD 120 million fundraising round, Shanghai-based EpimAb Biotherapeutics is now looking…
Canada / Top 10 Pharma Companies 2020 Ranking
The Top 10 companies in the Canadian pharma market for 2020, ranked by revenues in USD billions. J&J takes the…
Switzerland / Lonza Goes Big with Investments in Biologics, ADCs & Vaccines Manufacturing
In the last month alone, CDMO giant Lonza has announced three major upgrades to its manufacturing footprint in…
Argentina / Politics and Pharma M&A
The COVID-19 pandemic has caused economic and social disruption and affected the behaviour of both consumers and…
In Conversation
Ümit Dereli – Secretary General, AIFD, Turkey
Ümit Dereli is secretary general of the Turkish Association of Research-Based Pharmaceutical Companies (AIFD), which has 35 multinational member companies that together account for almost 50 percent of the Turkish market. In this interview, he discusses the impact of COVID-19 on the research-based, innovative, pharmaceutical industry in Turkey, AIFD initiatives to foster the biotech ecosystem, and how Turkey has set…
Latest Reports
Focus on MEA
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…
MENA Pharma News: Egypt Opens ‘Pharma City’;…
The latest Middle East and North Africa (MENA) pharma, including Egypt’s…
Turkey: Koçak Farma & The Push for Homegrown COVID-19…
As the international community continues its quest to vaccinate the global…
MEA: Iran looks to Cuba for COVID-19 Vaccine; Israel Leads…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
Read more: MEA >>
Focus on USA
USA: 2 Things the Biden Administration can do Now to Lower…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can…
NORD Chief Strategy Officer on Health Equity’s Vital…
With Rare Disease Day coming up on February 28th, one of the leading…
Mexico-US Vaccine Tourism: Closed Borders, Fear of Fakes…
While Mexico struggles with its COVID-19 vaccination campaign, residents of the…
US U-Turn as Biden Pledges Support for Waiver on COVID-19…
In a shock move, Joe Biden’s administration looks set to support a waiver on…
Read more: USA >>
Focus on Singapore
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
Singapore: Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long…
HSA: APAC’s Regulatory Gold Standard
As the most important pharma hub in its region, and one of the most important…
Medtech’s Post-COVID Paradigm in APAC
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech…
Read more: Singapore >>
Focus on China
Top 10 Chinese Pharma Companies 2020
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
Public Insurance Coverage for Rare Disease Patients in…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare…
China Pharma News: Antitrust Threat to Pharma; June BioNTech…
The latest China pharma news, including the upcoming first domestic approval for…
Read more: China >>
Focus on Switzerland
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
MSD Switzerland AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich…
Switzerland’s Quest for Alternatives to Animal Testing of…
Animal testing for medicinal purposes is back under the spotlight in Switzerland…
Lonza Goes Big with Swiss Investments in Biologics, ADCs…
In the last month alone, CDMO giant Lonza has announced three major upgrades to…
Read more: Switzerland >>
Focus on Vaccines
Turkey: Koçak Farma & The Push for Homegrown COVID-19…
As the international community continues its quest to vaccinate the global…
Lonza Goes Big with Swiss Investments in Biologics, ADCs…
In the last month alone, CDMO giant Lonza has announced three major upgrades to…
Korea Pharma News: Samsung Bioepis Goes Down Under;…
The latest news from Korean pharma, including how Korea can put the…
Vaccine Wars: What the EU/AstraZeneca Row Shows Us About…
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and…
Read more: Vaccines >>
Focus on Europe
MSD Switzerland AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich…
UK Pharma News: Fastest Growing Private Pharmacos; GSK…
The latest UK pharma news, including how new investment in GSK stands to reshape…
Vaccine Wars: What the EU/AstraZeneca Row Shows Us About…
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and…
Spanish Pharma News: Market Growth; Esteve’s US Expansion;…
The latest from Spanish pharma, including the acquisition of PTS by a private…